Latest Breaking News On - Nuclear receptors - Page 1 : vimarsana.com

UH Researcher on Team Developing Sense-and-Respond Cancer Implant Technology

Federally funded research project could slash US cancer deaths by half. Dr. Weiyi Peng, assistant professor of biology and biochemistry, is co-principal investigator and one of three group leaders of the project.

Making immunotherapy safer

Researchers at the University of Houston are working to make T-cell immunotherapy safer, developing a tool called CrossDome, which uses a combination of genetic and biochemical information to predict if T-cell immunotherapies might mistakenly attack healthy cells.

CrossDome tool helps predict the potential risks of T-cell immunotherapy

Researchers at the University of Houston are working to make T-cell immunotherapy safer, developing a tool called CrossDome, which uses a combination of genetic and biochemical information to predict if T-cell immunotherapies might mistakenly attack healthy cells.

New tool predicts if immunotherapy will mistakenly attack healthy cells

Study provides a possible treatment option for prostate cancer resistant to hormone therapy

Prostate cancer is the most-commonly diagnosed malignancy and the second leading cause of cancer death among men in the United States.